Research Briefing | Sep 21, 2021

Australia | Alternate recovery paths shaped by key risks

alternativerecovery

Vaccine programs across the world are well underway and should enable a sustained and meaningful easing of restrictions in late-2021 and early-2022. But as we have seen in Australia, vaccine rollouts have not been immune to supply disruptions and efficacy concerns, which are threatening to keep economies and international borders restricted for longer. Using our Global Economic Model, we consider three alternate recovery scenarios.
What you will learn:

  • In the first scenario, new virus variants result in renewed restrictions. Lower vaccine efficacy against more transmissible forms of coronavirus lead to the retention of public health measures for a protracted period.
  • In the second scenario, the recovery is delayed by consumer caution, vaccine hesitancy and a sluggish reduction in voluntary social distancing.
  • In the final scenario, households rapidly unwind savings accumulated during the pandemic, fuelling a sharp consumer-led rebound in the economy.
Tags: AustraliaConsumer recoveryConsumer spendingConsumptionCoronavirusCovid19MacroPost CovidRecoveryVaccinated travellersVaccine rolloutVaccines
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.